Carmell Therapeutics Stock (NASDAQ:ALPA)

Revenue Ownership Financials Chart

Previous Close

$9.79

52W Range

$8.73 - $11.83

50D Avg

$10.24

200D Avg

$10.04

Market Cap

$193.74M

Avg Vol (3M)

$184.85K

Beta

-

Div Yield

-

ALPA Company Profile

Alpha Healthcare Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. It focuses to source, acquire, and manage a business in the healthcare industry in the United States. The company was incorporated in 2021 and is based in New York, New York.

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Sep 23, 2021

Website

ALPA Performance

ALPA Financial Summary

	Dec 22	Dec 21
Revenue	-	-
Operating Income	$-1.65M	$-467.43K
Net Income	$205.00K	$-329.38K
EBITDA	$-3.90M	$-605.48K
Basic EPS	$0.01	$-0.03
Diluted EPS	$0.01	$-0.03

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison

Ticker	Company
ADER	26 Capital Acquisition Corp.
ANZU	Envoy Medical, Inc.
FACT	Complete Solaria, Inc.
AMAO	Royalty Management Holding Corporation
BYTS	Airship AI Holdings, Inc.